Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07306364) titled 'Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain' on Dec. 23, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Yale University
Condition:
Chronic Low Back Pain (CLBP)
Physical Therapy
Psilocybin
Intervention:
Drug: Psilocybin 10 mg
Drug: Psilocybin 25 mg
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: June 2026
Target Sample Size: 45
Countries of Recruitment:
United Sta...